loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people.
.
.
.
.
he said: "our research shows that people, on average, believe that only 34 per cent of protection claims are paid out by insurance companies.
.
.
.